The US FDA is warning of the potential risks associated with the use of some infants’ liquid vitamin D supplement products News item 18 January 2013 Pages: 3 - 3
Consumers have been warned by the US FDA about a potentially harmful product labelled as “Generic Tamiflu” being sold over the Internet Media release 18 January 2013 Pages: 3 - 3
The slow tapering of clonazepam was well tolerated without relapse, rebound, or withdrawal syndrome Clinical study 18 January 2013 Pages: 4 - 4
Sorafenib enhances the peripheral metabolism of thyroid hormones, likely by activity of type 3 deiodinase, which may contribute to hypothyroidism Clinical study 18 January 2013 Pages: 4 - 4
Ipilimumab: will benefits outweigh risks in the eyes of the FDA? News item 18 January 2013 Pages: 6 - 6
Rituximab-based chemotherapy may raise the risk of HBV* reactivation Clinical study 18 January 2013 Pages: 6 - 6
Testing for NT-proBNP* levels can predict the risk of major chemotherapy-related toxicity and death Clinical study 18 January 2013 Pages: 6 - 6
Acetylcysteine protective against TB drug-induced hepatotoxicity Clinical study 18 January 2013 Pages: 7 - 7
The risk of late-onset nosocomial pneumonia is increased in patients receiving ranitidine and omeprazole Clinical study 18 January 2013 Pages: 8 - 8
Lurasidone was determined to be ’safe’ and generally well tolerated across five placebo-controlled trials Clinical study 18 January 2013 Pages: 8 - 8
